Candel Therapeutics, Inc.CADLNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+19.6%
5Y CAGR+27.8%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+19.6%/yr
Annual compound
5Y CAGR
+27.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $119.73M | +16.6% |
| 2024 | $102.65M | +189.9% |
| 2023 | $35.41M | -49.5% |
| 2022 | $70.06M | -15.2% |
| 2021 | $82.64M | +135.8% |
| 2020 | $35.05M | +576.8% |
| 2019 | $5.18M | - |